Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Touts Vertical Integration As Key To Traceability, Cost Control

This article was originally published in The Tan Sheet

Executive Summary

Herbalife looks to improve its bottom line by bringing its manufacturing and sourcing functions in-house, according to Chief Financial Officer John DeSimone

You may also be interested in...



Herbalife Investments Streamline Supply Chain, Attract Industry Talent

Herbalife’s “seed-to-feed” vertical integration strategy includes a $130 million facility in North Carolina to open in 2014 and the continued recruitment of dietary supplement scientific and regulatory experts. The multilevel marketer also is deploying novel modes of product distribution across its markets.

Herbalife Investments Streamline Supply Chain, Attract Industry Talent

Herbalife’s “seed-to-feed” vertical integration strategy includes a $130 million facility in North Carolina to open in 2014 and the continued recruitment of dietary supplement scientific and regulatory experts. The multilevel marketer also is deploying novel modes of product distribution across its markets.

Herbalife Shakes Off Market Dive After Investor Scare

David Einhorn’s questions during Herbalife’s Q1 earnings call sowed market doubt about the firm, whose stock dropped about 20% May 1. But analysts called the panic behind the sell-off “unwarranted” given the firm’s strong Q1 performance and sound fundamentals.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104250

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel